Showing results (331-340 of 376) with videos related to

Sort By:
Pageof 38
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Controlled trial of dexverapamil, a modulator of multidrug resistance, in lymphomas refractory to EPOCH chemotherapyW H Wilson, S E Bates, A Fojo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1995
Phase II study of paclitaxel in relapsed non-Hodgkin's lymphomasW H Wilson, B A Chabner, G Bryant, et al.
Annals of Internal Medicine|February 1, 1983
The human T-cell leukemia/lymphoma virus, lymphoma, lytic bone lesions, and hypercalcemiaD W Blayney, E S Jaffe, R I Fisher, et al.
International Journal of Cancer|November 15, 1994
Adult T-cell leukemia/lymphoma: a working point-score classification for epidemiological studiesP H Levine, F Cleghorn, A Manns, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1993
EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphomaW H Wilson, G Bryant, S Bates, et al.
Journal of the National Cancer Institute|February 1, 1985
Cytogenetic studies in human T-cell lymphoma virus (HTLV)-positive leukemia-lymphoma in the United StatesJ Whang-Peng, P A Bunn, T Knutsen, et al.
Nature Genetics|January 13, 1998
FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndromeS Xiao, S R Nalabolu, J C Aster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2000
Modulation of clinical drug resistance in a B cell lymphoma patient by the protein kinase inhibitor 7-hydroxystaurosporine: presentation of a novel therapeutic paradigmW H Wilson, L Sorbara, W D Figg, et al.
Cancer|June 1, 1989
Human T-cell leukemia virus-I and hematologic malignancies in PanamaP H Levine, W C Reeves, M Cuevas, et al.
Pageof 38